ConductScience.org, home

Trial · NCT00129467

Methylphenidate for Depressed Cancer Patients Receiving Palliative Care

NCT00129467, Not applicable, Completed, US Department of Veterans Affairs; results first posted 2014-02-12

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Methylphenidate for Depressed Cancer Patients Receiving Palliative Care. Trials, record NCT00129467. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00129467

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Methylphenidate for Depressed Cancer Patients Receiving Palliative Care
NCT number
NCT00129467
Status
Completed
Phases
Not applicable
Enrollment
47 participants, actual
Lead sponsor
US Department of Veterans Affairs
Conditions
Depression, Palliative Care, Cancer, Mental Disorder
Interventions
Methylphenidate, Placebo, Selective Serotonin Uptake Inhibitor (SSRI)
First posted
2005-08-11
Last updated
2015-04-24
Results first posted
2014-02-12
Limitations and caveats
Frequency threshold for reporting nonserious adverse events was not determined at the start of the study, but a % was required to be entered in order to complete the adverse event module

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDays to Remission of Depression18 DaysDays to a 50% or greater reduction in initial Montgomery-Asberg Depression Rating Scale (MADRS) score.

Outcomes1

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYDays to Remission of Depression18 DaysThe number of participants analyzed is the number of who received the interventionDaysMEAN

Results by group2

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Days to Remission of DepressionMethylphenidate + SSRI10.3Standard Error 1.77Days
Days to Remission of DepressionPlacebo + SSRI8.1Standard Error 1.31Days

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Received InterventionSTARTEDMethylphenidate + SSRI15
Received InterventionSTARTEDPlacebo + SSRI17
Received InterventionCOMPLETEDMethylphenidate + SSRI9
Received InterventionCOMPLETEDPlacebo + SSRI13
Received InterventionNOT COMPLETEDMethylphenidate + SSRI6
Received InterventionNOT COMPLETEDPlacebo + SSRI4
Open Label for SSRI+Methylphenidate ArmSTARTEDMethylphenidate + SSRI4
Open Label for SSRI+Methylphenidate ArmSTARTEDPlacebo + SSRI0
Open Label for SSRI+Methylphenidate ArmCOMPLETEDMethylphenidate + SSRI2
Open Label for SSRI+Methylphenidate ArmCOMPLETEDPlacebo + SSRI0

Adverse events4

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
seriousDeathNeoplasms benign, malignant and unspecified (incl cysts and polyps)Methylphenidate + SSRI6156
seriousDeathNeoplasms benign, malignant and unspecified (incl cysts and polyps)Placebo + SSRI3173
seriousNew cardiac symptomCardiac disordersMethylphenidate + SSRI1151
seriousNew cardiac symptomCardiac disordersPlacebo + SSRI1171

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityMethylphenidate + SSRI
Total, all-cause mortalityPlacebo + SSRI
Total, other adverse eventsMethylphenidate + SSRI015
Total, other adverse eventsPlacebo + SSRI017
Total, serious adverse eventsMethylphenidate + SSRI715
Total, serious adverse eventsPlacebo + SSRI417

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
36999619DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons1

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison
Methylphenidate + SSRI vs Placebo + SSRI: serious adverse events

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00129467

GET https://conductscience.org/api/trials/v1/NCT00129467/registered